ReviewInternational journal of vascular medicine2015
Treatment of Intravenous Leiomyomatosis with Cardiac Extension following Incomplete Resection.
Review in International journal of vascular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 38 citations in OpenAlex.
- Clinical analysis of nine cases of uterine intravenous leiomyomatosis and review of the literature.Medicine · 2026Review
- Benign Metastasizing Leiomyoma Presenting as a Right Ventricular Mass.JACC. Case reports · 2025Article
- Intracardiac Leiomyoma Leading to Liver Failure and Heart Failure Managed by VA-ECMO and Surgical Resection.JACC. Case reports · 2025Article
- Uterine Intravenous Leiomyomatosis with Internal Iliac Artery Involvement.International journal of women's health · 2025Article
- Intravenous Leiomyomatosis of the Uterus Extending to the Right Atrium: A Case Report.Annals of vascular diseases · 2025Article
- Analysis of risk factors for post-operative recurrence or progression of intravenous leiomyomatosis.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2024Article
- Update on clinical characteristics and molecular insights for uterine intravenous leiomyomatosis (Review).Oncology letters · 2024Review
- Surgical management of intravenous leiomyomatosis with intracardiac extension.Journal of vascular surgery cases and innovative techniques · 2023Article
- Intracaval Leiomyoma with Intracardiac Extension.The International journal of angiology : official publication of the International College of Angiology, Inc · 2023Article
- Bilateral Salpingo-Oophorectomy for Intracardiac Leiomyomatosis: A Case Report.The American journal of case reports · 2022Article
- One-stage resection of intravascular leiomyomatosis involving the right heart chamber through a single laparotomy.Frontiers in cardiovascular medicine · 2022Article
- Gynecologists Need to Be Vigilant-Two Case Reports of Intravascular Leiomyomatosis and Literature Review.Frontiers in oncology · 2022Review
- Clinical analysis of uterine intravenous leiomyomatosis: A retrospective study of 260 cases.The journal of obstetrics and gynaecology research · 2021Article
- Uterineintravenous leiomyomatosis with cardiac involvement.Radiology case reports · 2020Article
- Surgical treatment strategies for extra-pelvic intravenous leiomyomatosis.Orphanet journal of rare diseases · 2020Article
- Multidisciplinary management of extensive intravenous leiomyomatosis: A coordinated effort of a single institution.Gynecologic oncology reports · 2020Article
- Computed tomography evaluation of extensive intravenous angioleiomyoma: a case report.BMC medical imaging · 2020Article
- Perioperative management of intracardiac leiomyomatosis: An observational cohort study.Medicine · 2017Observational
- Post-hysterectomy intravenous leiomyomatosis: A case of successful multidisciplinary surgery under non-extracorporeal circulation.Molecular and clinical oncology · 2017Article
- Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim. Intravenous leiomyomatosis (IVL) with cardiac extension (CE) is a rare variant of benign uterine leiomyoma. Incomplete resection has a recurrence rate of over 30%. Different hormonal treatments have been described following incomplete resection; however no standard therapy currently exists. We review the literature for medical treatments options following incomplete resection of IVL with CE. Methods. Electronic databases were searched for all studies reporting IVL with CE. These studies were then searched for reports of patients with inoperable or incomplete resection and any further medical treatments. Our database was searched for patients with medical therapy following incomplete resection of IVL with CE and their results were included. Results. All studies were either case reports or case series. Five literature reviews confirm that surgery is the only treatment to achieve cure. The uses of progesterone, estrogen modulation, gonadotropin-releasing hormone antagonism, and aromatase inhibition have been described following incomplete resection. Currently no studies have reviewed the outcomes of these treatments. Conclusions. Complete surgical resection is the only means of cure for IVL with CE, while multiple hormonal therapies have been used with varying results following incomplete resection. Aromatase inhibitors are the only reported treatment to prevent tumor progression or recurrence in patients with incompletely resected IVL with CE.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.